A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis
Clinical trial NCT04109976 · COMPLETED
Trial details
- NCT number
- NCT04109976
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-13
- Primary completion
- 2020-11-05
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.